title: Phagocytosis of Staphylococcus aureus by human neutrophils prevents macrophage efferocytosis and induces programmed necrosis.
abstract: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) pose a significant threat to human health. Polymorphonuclear leukocytes (PMN) are the first responders during staphylococcal infection, but 15-50% of the initial ingested inoculum survives within the PMN phagosome and likely contributes directly or indirectly to disease pathogenesis. We hypothesize that surviving intracellular CA-MRSA undermine effective phagocyte-mediated defense by causing a decrease in macrophage uptake of PMN containing viable S. aureus and by promoting PMN lysis. In support of this hypothesis, PMN harboring viable CA-MRSA strain USA300 (PMN-SA) upregulated the "don't eat me" signal CD47, remained bound to the surface, and were inefficiently ingested by macrophages. In addition, coculture with PMN-SA altered the macrophage phenotype. Compared to macrophages fed USA300 alone, macrophages challenged with PMN-SA produced more IL-8 and less IL-1 receptor antagonist, TNF-α, activated caspase-1, and IL-1β. Although they exhibited some features of apoptosis within 3 h following ingestion of S. aureus, including phosphatidylserine exposure and mitochondrial membrane depolarization, PMN-SA had sustained levels of proliferating cell nuclear Ag expression, absence of caspase activation, and underwent lysis within 6 h following phagocytosis. PMN lysis was dependent on receptor-interacting protein 1, suggesting that PMN-SA underwent programmed necrosis or necroptosis. These data are the first demonstration, to our knowledge, that bacteria can promote sustained expression of proliferating cell nuclear Ag and that human PMN undergo necroptosis. Together, these findings demonstrate that S. aureus surviving within PMN undermine the innate immune response and may provide insight into the pathogenesis of S. aureus disease.
authors.affiliation: Inflammation Program, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Veterans Administration Medical Center, Iowa City, IA 52240;
authors.forename: Mallary C
authors.initials: MC
authors.lastname: Greenlee-Wacker
authors.forename: Kevin M
authors.initials: KM
authors.lastname: Rigby
authors.forename: Scott D
authors.initials: SD
authors.lastname: Kobayashi
authors.forename: Adeline R
authors.initials: AR
authors.lastname: Porter
authors.forename: Frank R
authors.initials: FR
authors.lastname: DeLeo
authors.forename: William M
authors.initials: WM
authors.lastname: Nauseef
mesh_terms: D017209:Apoptosis / Q000276:immunology*; D051928:CD47 Antigen / Q000276:immunology; D020170:Caspase 1 / Q000276:immunology; D018920:Coculture Techniques; D005260:Female; D006801:Humans; D053583:Interleukin-1beta / Q000276:immunology; D008264:Macrophages / Q000276:immunology* / Q000473:pathology; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000276:immunology*; D009336:Necrosis / Q000276:immunology / Q000473:pathology; D009504:Neutrophils / Q000276:immunology* / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
chemical_list: D051928:CD47 Antigen; C497894:CD47 protein, human; C508585:IL1B protein, human; D053583:Interleukin-1beta; D014409:Tumor Necrosis Factor-alpha; D020170:Caspase 1
references.citation: Methods Mol Biol. 2007;412:15-20
references.pmid: 18453102
references.citation: J Immunol. 2008 Jul 1;181(1):364-73
references.pmid: 18566402
references.citation: J Immunol. 2000 Apr 1;164(7):3713-22
references.pmid: 10725730
references.citation: Immunity. 2006 Jan;24(1):79-91
references.pmid: 16413925
references.citation: PLoS Pathog. 2012;8(11):e1003047
references.pmid: 23209417
references.citation: Cell Cycle. 2012 Feb 1;11(3):460-7
references.pmid: 22274400
references.citation: Immunol Rev. 2007 Oct;219:88-102
references.pmid: 17850484
references.citation: Nature. 2002 Jul 11;418(6894):200-3
references.pmid: 12110892
references.citation: Sci Signal. 2010 Mar 30;3(115):re4
references.pmid: 20354226
references.citation: Cell. 2003 Oct 3;115(1):13-23
references.pmid: 14531999
references.citation: J Leukoc Biol. 2006 Jan;79(1):87-94
references.pmid: 16244110
references.citation: J Clin Invest. 2009 Sep;119(9):2464-74
references.pmid: 19729844
references.citation: J Immunol. 2009 Aug 15;183(4):2632-41
references.pmid: 19620311
references.citation: J Immunol. 2007 Nov 15;179(10):6933-42
references.pmid: 17982084
references.citation: J Exp Med. 2010 Nov 22;207(12):2631-45
references.pmid: 20975039
references.citation: J Clin Invest. 1998 Feb 15;101(4):890-8
references.pmid: 9466984
references.citation: Lancet. 2010 May 1;375(9725):1557-68
references.pmid: 20206987
references.citation: Curr Protoc Cell Biol. 2003 Feb;Chapter 16:Unit 16.4
references.pmid: 18228421
references.citation: J Immunol. 2005 Sep 15;175(6):3907-19
references.pmid: 16148137
references.citation: J Immunol. 1995 Aug 1;155(3):1428-33
references.pmid: 7636208
references.citation: J Leukoc Biol. 2006 Sep;80(3):563-71
references.pmid: 16816147
references.citation: PLoS One. 2010 Jul 16;5(7):e11634
references.pmid: 20661294
references.citation: FEBS Lett. 1999 Jun 18;453(1-2):67-71
references.pmid: 10403377
references.citation: Cell. 2009 Jun 12;137(6):1100-11
references.pmid: 19524512
references.citation: J Innate Immun. 2010;2(6):546-59
references.pmid: 20829608
references.citation: J Immunol. 2009 Sep 15;183(6):3942-8
references.pmid: 19717510
references.citation: J Innate Immun. 2010;2(6):560-75
references.pmid: 20587998
references.citation: Blood. 2009 Jul 23;114(4):860-70
references.pmid: 19398720
references.citation: J Leukoc Biol. 2013 Feb;93(2):185-98
references.pmid: 23066164
references.citation: J Exp Med. 1956 Jun 1;103(6):713-42
references.pmid: 13319588
references.citation: J Immunol. 2012 Apr 1;188(7):3351-63
references.pmid: 22357630
references.citation: Cell. 2005 Oct 21;123(2):321-34
references.pmid: 16239148
references.citation: J Leukoc Biol. 2007 Aug;82(2):259-64
references.pmid: 17470531
references.citation: Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11784-9
references.pmid: 18689689
references.citation: Semin Immunopathol. 2012 Mar;34(2):237-59
references.pmid: 22080185
references.citation: J Exp Med. 1952 Feb;95(2):209-30
references.pmid: 14907971
references.citation: Oncogene. 2012 Dec 6;31(49):5045-60
references.pmid: 22310284
references.citation: Immunity. 2013 Feb 21;38(2):209-23
references.pmid: 23438821
references.citation: PLoS One. 2010 Apr 14;5(4):e10146
references.pmid: 20418950
references.citation: Curr Opin Microbiol. 2012 Feb;15(1):28-35
references.pmid: 22137885